PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.
about
Polo-like kinase and its inhibitors: Ready for the match to start?Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights.Molecular targeting of the oncoprotein PLK1 in pediatric acute myeloid leukemia: RO3280, a novel PLK1 inhibitor, induces apoptosis in leukemia cells.Rational Combinations of Targeted Agents in AMLAlternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.Volasertib suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.Romidepsin for the treatment of non-Hodgkin's lymphoma.HDAC1 inhibition by melatonin leads to suppression of lung adenocarcinoma cells via induction of oxidative stress and activation of apoptotic pathways.Natural Agents-Mediated Targeting of Histone Deacetylases.Replication Stress Leading to Apoptosis within the S-phase Contributes to Synergism between Vorinostat and AZD1775 in HNSCC Harboring High-Risk TP53 Mutation.
P2860
Q28087433-2AF7848F-E582-4C0A-93FC-4D823D51AA80Q33983255-B171C2DE-8CBC-4171-94D4-78179781E090Q35016583-62AFE180-0EBE-4257-9F49-F3CB04DA3DEFQ35750491-7A40FE02-914E-4AD8-8B65-16B79DDA4922Q35931271-9738C671-8BF0-4171-8A1D-A0115AE6CA85Q37447866-FF97F6F7-FC2E-4133-9EFE-7A0045445225Q38455740-9EA5DC8D-DCA0-4150-BD69-11CDA049D99BQ38851907-F30AA5FB-B8F8-4955-86B7-C0F0F18293E5Q47740361-99A4B432-3DF7-4A88-9EE3-E892E2A88F54Q48698494-527084FB-1599-4636-977C-1BB55F3144A1
P2860
PLK1 inhibitors synergistically potentiate HDAC inhibitor lethality in imatinib mesylate-sensitive or -resistant BCR/ABL+ leukemia cells in vitro and in vivo.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@ast
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@en
type
label
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@ast
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@en
prefLabel
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@ast
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@en
P2093
P2860
P1476
PLK1 inhibitors synergisticall ...... ia cells in vitro and in vivo.
@en
P2093
Elisa Attkisson
Girija Dasmahapatra
Hiral Patel
Steven Grant
Tri Nguyen
P2860
P304
P356
10.1158/1078-0432.CCR-12-2799
P407
P577
2012-11-30T00:00:00Z